Genic Co. Ltd
Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; a… Read more
Genic Co. Ltd (123330) - Net Assets
Latest net assets as of September 2025: ₩34.93 Billion KRW
Based on the latest financial reports, Genic Co. Ltd (123330) has net assets worth ₩34.93 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩50.21 Billion) and total liabilities (₩15.28 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩34.93 Billion |
| % of Total Assets | 69.57% |
| Annual Growth Rate | -6.99% |
| 5-Year Change | -0.79% |
| 10-Year Change | -61.83% |
| Growth Volatility | 31.47 |
Genic Co. Ltd - Net Assets Trend (2012–2024)
This chart illustrates how Genic Co. Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Genic Co. Ltd (2012–2024)
The table below shows the annual net assets of Genic Co. Ltd from 2012 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩22.15 Billion | +92.12% |
| 2023-12-31 | ₩11.53 Billion | -27.67% |
| 2022-12-31 | ₩15.94 Billion | -17.38% |
| 2021-12-31 | ₩19.30 Billion | -13.59% |
| 2020-12-31 | ₩22.33 Billion | -17.72% |
| 2019-12-31 | ₩27.14 Billion | -30.31% |
| 2018-12-31 | ₩38.94 Billion | -28.25% |
| 2017-12-31 | ₩54.27 Billion | -12.37% |
| 2016-12-31 | ₩61.93 Billion | +6.70% |
| 2015-12-31 | ₩58.04 Billion | +5.23% |
| 2014-12-31 | ₩55.16 Billion | +3.59% |
| 2013-12-31 | ₩53.25 Billion | +0.72% |
| 2012-12-31 | ₩52.87 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Genic Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 617437725000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ₩28.33 Billion | 127.87% |
| Total Equity | ₩22.15 Billion | 100.00% |
Genic Co. Ltd Competitors by Market Cap
The table below lists competitors of Genic Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
HusCompagniet AS
CO:HUSCO
|
$85.49 Million |
|
Shaver Shop Group Ltd
AU:SSG
|
$85.52 Million |
|
Lollands Bank
CO:LOLB
|
$85.53 Million |
|
Perfect Medical Health Management Limited
PINK:PFSMF
|
$85.55 Million |
|
Peninsula Energy Ltd
OTCQB:PENMF
|
$85.48 Million |
|
Pro-Hawk
TWO:8083
|
$85.48 Million |
|
Westwater Resources Inc
NYSE MKT:WWR
|
$85.48 Million |
|
Empire Metals Limited
OTCQB:EPMLF
|
$85.39 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Genic Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 11,531,444,970 to 22,154,400,820, a change of 10,622,955,850 (92.1%).
- Net income of 7,562,687,680 contributed positively to equity growth.
- Share repurchases of 3,000,001,960 reduced equity.
- New share issuances of 3,000,001,960 increased equity.
- Other factors increased equity by 3,060,268,170.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩7.56 Billion | +34.14% |
| Share Repurchases | ₩3.00 Billion | -13.54% |
| Share Issuances | ₩3.00 Billion | +13.54% |
| Other Changes | ₩3.06 Billion | +13.81% |
| Total Change | ₩- | 92.12% |
Book Value vs Market Value Analysis
This analysis compares Genic Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 9.36x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 2.94x to 9.36x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩9025.19 | ₩26500.00 | x |
| 2017-12-31 | ₩7913.09 | ₩26500.00 | x |
| 2018-12-31 | ₩5679.82 | ₩26500.00 | x |
| 2019-12-31 | ₩3958.51 | ₩26500.00 | x |
| 2020-12-31 | ₩3257.13 | ₩26500.00 | x |
| 2021-12-31 | ₩2814.64 | ₩26500.00 | x |
| 2022-12-31 | ₩2325.39 | ₩26500.00 | x |
| 2023-12-31 | ₩1681.95 | ₩26500.00 | x |
| 2024-12-31 | ₩2831.35 | ₩26500.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Genic Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 34.14%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 15.15%
- • Asset Turnover: 1.31x
- • Equity Multiplier: 1.72x
- Recent ROE (34.14%) is above the historical average (-10.49%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 10.74% | 6.62% | 1.43x | 1.14x | ₩392.57 Million |
| 2013 | 6.48% | 5.55% | 0.96x | 1.22x | ₩-1.87 Billion |
| 2014 | 3.55% | 3.08% | 0.84x | 1.37x | ₩-3.56 Billion |
| 2015 | 5.04% | 3.97% | 0.85x | 1.50x | ₩-2.88 Billion |
| 2016 | 1.98% | 1.37% | 0.88x | 1.64x | ₩-4.97 Billion |
| 2017 | -13.76% | -11.54% | 0.69x | 1.72x | ₩-12.89 Billion |
| 2018 | -39.35% | -22.20% | 0.94x | 1.88x | ₩-19.22 Billion |
| 2019 | -44.07% | -22.88% | 0.90x | 2.14x | ₩-14.67 Billion |
| 2020 | -19.50% | -10.33% | 0.84x | 2.24x | ₩-6.59 Billion |
| 2021 | -22.44% | -11.28% | 0.85x | 2.35x | ₩-6.26 Billion |
| 2022 | -20.95% | -10.62% | 1.04x | 1.90x | ₩-4.93 Billion |
| 2023 | -38.25% | -15.71% | 1.20x | 2.03x | ₩-5.56 Billion |
| 2024 | 34.14% | 15.15% | 1.31x | 1.72x | ₩5.35 Billion |
Industry Comparison
This section compares Genic Co. Ltd's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $1,255,204,097,239
- Average return on equity (ROE) among peers: 165.42%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Genic Co. Ltd (123330) | ₩34.93 Billion | 10.74% | 0.44x | $85.48 Million |
| Amore Group (002790) | $4.89 Trillion | 5.33% | 0.26x | $733.67 Million |
| Amorepacific Group (002795) | $6.99 Trillion | 3.60% | 0.22x | $333.07 Million |
| Hankook Cosmetics Manufacturing Co Ltd (003350) | $25.45 Billion | -9.21% | 0.59x | $50.11 Million |
| Daelim Trading (006570) | $76.43 Billion | -16.61% | 1.09x | $3.62 Million |
| Monalisa (012690) | $54.46 Billion | 10.90% | 0.28x | $26.00 Million |
| Leaders Cosmetics Co. Ltd (016100) | $63.99 Billion | 24.29% | 0.52x | $13.95 Million |
| Aekyung Industrial Co Ltd (018250) | $333.04 Billion | 3.44% | 0.30x | $78.84 Million |
| Kolmar Holding (024720) | $48.25 Billion | 5.20% | 0.61x | $69.59 Million |
| Jayjun Co Ltd (025620) | $4.96 Billion | 1635.91% | 10.27x | $4.89 Million |
| Coreana Cosmetics Co.Ltd (027050) | $65.95 Billion | -8.68% | 0.74x | $33.77 Million |